Nephroplus, the dialysis care provider, announced $45 Mn(Rs 323 Cr) in Series D funding led by global alternative asset manager Investcorp. To date, Nephroplus has raised 200 crore funding from investors such as International Finance Corporation, SeaLink Capital and Bessemer Venture Capital, in its push to become the largest dialysis provider in the private sector. In an exclusive interview to IndiaMedToday, Vikram Vuppala, Founder CEO, Nephroplus said that the funds would serve as primary capital for growth as well as secondary capital which will be used to exit SeaLink Capital and a large angel investor and partial minor liquidity for few management teammates.
Hyderabad based Nephroplus is a dialysis provider with 183 dialysis centres across 100 cities and 18 states. The company leverages technology and automation to provide highest quality dialysis service at affordable prices.
India offers dialysis providers enormous growth potential. In fact, over 2,00,000 new End Stage Renal Disease (ESRD) patients are said to be added to the disease burden each year in India. “Only 15 per cent of patients with kidney failure in India today are able to access dialysis. In fact, this figure is upwards of 40 per cent in South East Asia,” said Vuppala. However, there is a lot of room for growth. “Organized market run by pure play dialysis networks is only 20 percent of overall dialysis market. Our overall market share is 12% only and there is a lot of headroom for growth,” said Vuppala.
The company plans to continue expansion via partnering with hospitals in India also expansion in few overseas markets in Asia and Middle East.